ANGO vs BWAY: stock comparison and AI forecast
Angiodynamics Inc (ANGO) and Brainsway Ltd. (BWAY) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ANGO Angiodynamics Inc
- Price
- $11.73 +4.1% · 6M
- Market Cap
- $493M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
BWAY Brainsway Ltd.
- Price
- $11.15 -33.4% · 6M
- Market Cap
- $437M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- ANGO is 1.1 times larger than BWAY by market capitalization ($493M against $437M).
- Over the last six months ANGO returned +4.1% and BWAY -33.4%.
- Both companies share the SEC industry classification Surgical & Medical Instruments & Apparatus.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ANGO | BWAY |
|---|---|---|
| Market Cap | $493M | $437M |
| P/B Ratio | 3.01x | – |
| EPS | $-0.79 | – |
| Book Value/Share | $3.90 | – |
| Revenue/Share | $7.74 | – |
| FCF/Share | $0.03 | – |
Profitability & Margins
| Metric | ANGO | BWAY |
|---|---|---|
| ROE | -23.2% | – |
| ROA | -15.7% | – |
| ROIC | -20.1% | – |
| Gross Margin | 55.6% | – |
| Operating Margin | -11.0% | – |
| Net Margin | -11.4% | – |
| EBT Margin | -9.8% | – |
| Tax Rate | -0.5% | – |
Financial Health
| Metric | ANGO | BWAY |
|---|---|---|
| Current Ratio | 2.40x | – |
| Quick Ratio | 1.48x | – |
| D/E Ratio | 0.48x | – |
| Financial Leverage | 1.48x | – |
| Interest Coverage | 25.5x | – |
| Working Capital | $83M | – |
Cash Flow
| Metric | ANGO | BWAY |
|---|---|---|
| Operating Cash Flow | $4M | – |
| Free Cash Flow | $1M | – |
| Capital Spending | -$2M | – |
| FCF/Sales | 0.4% | – |
| CapEx/Sales | 0.7% | – |
Operational Efficiency
| Metric | ANGO | BWAY |
|---|---|---|
| Asset Turnover | 1.34x | – |
| Receivables Turnover | 7.2x | – |
| Inventory Turnover | 2.6x | – |
| Fixed Assets Turnover | 11.7x | – |
| Days Sales Outstanding | 50 days | – |
| Days Inventory | 139 days | – |
| Payables Period | 67 days | – |
| Cash Conversion Cycle | 122 days | – |
Income Statement
| Metric | ANGO | BWAY |
|---|---|---|
| Total Revenue | $325M | – |
| Operating Income | -$37M | – |
| Net Income | -$38M | – |
| R&D Expense | $31M | – |
| SG&A Expense | $187M | – |
| Cost of Goods Sold | $144M | – |
Dividend & Shareholder Information
| Metric | ANGO | BWAY |
|---|---|---|
| Shares Outstanding | 42M | 39M |
ANGO vs BWAY: stock comparison and AI forecast
Which is bigger, ANGO or BWAY?
ANGO is 1.1 times larger than BWAY by market capitalization ($493M against $437M).
Which stock performed better over the last six months, ANGO or BWAY?
Over the last six months ANGO returned +4.1% and BWAY -33.4%.
Which one does Intratio's AI model rank higher, ANGO or BWAY?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.